Publications by authors named "Roger Morgan"

Claim this Profile
T
The Essential Role of Medical Monitors in Clinical Trials.
Gerald L Klein, Elizabeth Barabash, Roger E Morgan, Gail Brown, Mark Tulchinskiy

Cureus· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.
Kelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo, Carla M Yuede, Lora Waybright, Roger Morgan

Transl Neurodegener· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease.
Michael Grundman, Roger Morgan, Jason D Lickliter, Lon S Schneider, Steven DeKosky

Alzheimers Dement (N Y)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial.
Craig A Sponseller, Roger E Morgan, Vladimir A Kryzhanovski, Stuart E Campbell, Michael H Davidson

Clin Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady-state pharmacokinetics of darunavir/ritonavir and pitavastatin when co-administered to healthy adult volunteers.
Christine Y Yu, Stuart E Campbell, Craig A Sponseller, David S Small, Matthew M Medlock, Roger E Morgan

Clin Drug Investig· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the safety, tolerability, and pharmacokinetic profile of a single oral dose of pitavastatin 4 mg in adult subjects with severe renal impairment not on hemodialysis versus healthy adult subjects.
Roger E Morgan, Stuart E Campbell, Christine Y Yu, Craig A Sponseller, Heather A Muster

J Cardiovasc Pharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of steady-state lopinavir/ritonavir on the pharmacokinetics of pitavastatin in healthy adult volunteers.
Roger E Morgan, Stuart E Campbell, Kazuhito Suehira, Craig A Sponseller, Christine Y Yu

J Acquir Immune Defic Syndr· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication.
Eric P Brass, Leslie T Cooper, Roger E Morgan, William R Hiatt

J Vasc Surg· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.
Christine Y Yu, Stuart E Campbell, Baojin Zhu, Mary Pat Knadler, David S Small, Roger E Morgan

Curr Med Res Opin· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-drug interaction study to assess the effects of multiple-dose pitavastatin on steady-state warfarin in healthy adult volunteers.
Yoichiro Inagaki, Thomas Hunt, Bill Arana, Masahiko Gosho, Roger Morgan

J Clin Pharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer.
Mark Davies, Ponnandai J Arumugam, Varsha I Shah, Alun Watkins, Andrew Roger Morgan

Clin Transl Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine receptor CXCR3 desensitization by IL-16/CD4 signaling is dependent on CCR5 and intact membrane cholesterol.
Shilpa Rahangdale, Roger Morgan, Claudia Heijens, Thomas C Ryan, Hisato Yamasaki

J Immunol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis